ASSEMBLY BIOSCIENCES, INC.

ASMB

ASSEMBLY BIOSCIENCES, INC.

ASMB

Insider Sentiment (TTM):

Last Purchase:2025-08-08Last Sale:2026-06-17Shares Purchased (TTM):2,295,920Shares Sold (TTM):554

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:13,469,640Shares Outstanding:16,900,232Institutional Ownership Pct.:79.70%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	31	58	23	24	23	38	28	19	19	20	27	22
Available For Sale Securities Debt Securities Curr…	195	190	210	51	68	74	67	90	94	110	20	38
Accounts Receivable Net Current	0	1	1	-	-	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	6	5	3	2	4	3	3	4	4	3	3	4
Assets Current	233	255	237	77	96	116	98	113	117	134	50	64
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	1	1
Operating Lease Right Of Use Asset	2	3	3	3	3	3	1	2	2	2	1	2
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	1	0
Assets	236	258	240	81	99	119	100	115	120	137	52	67
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	2	1	1	1	1	1	1	0	1	1
Other Accrued Liabilities Current	3	8	6	3	2	7	5	4	2	6	4	4
Contract With Customer Liability Current	29	37	42	41	41	38	33	33	33	31	-	-
Operating Lease Liability Current	1	1	1	1	1	0	1	1	1	1	1	2
Liabilities Current	35	49	53	47	47	48	42	41	39	39	7	9
Contract With Customer Liability Noncurrent	-	0	2	13	23	35	33	39	48	55	3	3
Operating Lease Liability Noncurrent	2	2	2	2	2	3	0	0	1	1	0	0
Liabilities	37	51	57	63	72	86	74	81	87	96	10	12
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,040	1,039	1,037	863	862	859	842	841	828	827	817	816
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-841	-832	-854	-845	-835	-826	-816	-806	-795	-786	-775	-760
Stockholders Equity	199	207	183	18	27	33	26	35	33	41	42	55
Liabilities And Stockholders Equity	236	258	240	81	99	119	100	115	120	137	52	67
Related Party	-	-	-	-	-	-	-	-	-	31	-	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	64	63	63	61	61	60	57	57	55	55	53	52
Shares Outstanding	16	16	16	8	8	7	6	6	5	5	4	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-10.57%	-13.55%	-17.39%	-	-	-	-	-	-	-	-	-
2025	21.36%	48.46%	59.09%	27.12%	26.97%	50.49%	9.17%	5.24%	-19.61%	3.31%	8.11%	-16.76%
2024	17.90%	6.77%	16.26%	21.52%	18.01%	26.38%	-2.63%	-13.37%	-15.60%	-15.06%	14.50%	51.92%
2023	-	-	-	-7.55%	-16.04%	-22.64%	-15.29%	-3.53%	5.88%	0.83%	9.25%	15.71%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	6.65	5.22	4.44	1.64	2.05	2.42	2.36	2.74	3.02	3.41	6.96	7.26
Quick Ratio	6.49	5.11	4.37	1.59	1.95	2.34	2.28	2.65	2.92	3.32	6.48	6.81
Working Capital	197.62M	205.77M	183.43M	30.18M	48.90M	67.70M	56.58M	71.66M	78.42M	94.56M	42.54M	55.25M
Leverage & Debt
Debt to Equity	0.19	0.25	0.31	3.46	2.65	2.57	2.86	2.33	2.68	2.33	0.24	0.21
Debt Ratio	0.16	0.20	0.24	0.78	0.73	0.72	0.74	0.70	0.73	0.70	0.19	0.17
Efficiency & Turnover
Asset Turnover TTM	0.17	0.16	0.22	0.34	0.29	0.22	0.37	0.24	0.13	0.06	0.00	0.00
Days Sales Outstanding TTM	5.75	11.92	8.95	-	-	-	-	-	10.71	25.15	-	-
Receivables Turnover TTM	63.48	30.63	40.78	-	-	-	-	-	34.07	14.51	-	0.00
Per Share Metrics
Diluted EPS TTM	-0.38	-0.55	-3.04	-5.09	-5.32	-6.69	-6.42	-8.08	-9.37	-13.38	-16.59	-18.69
Free Cash Flow Per Share TTM	-2.36	-3.67	-4.40	-7.30	-7.49	-8.52	3.59	4.26	5.02	4.89	-16.07	-17.53
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-47.32%	-40.62%	-116.83%	-130.91%	-138.81%	-159.26%	-163.94%	-235.24%	-431.08%	-902.50%	-	-
Net Profit Margin TTM	-22.30%	-20.52%	-103.65%	-117.20%	-124.15%	-140.87%	-144.05%	-212.33%	-396.62%	-854.78%	-	-
Growth Metrics
Net Revenue Growth (1Y)	-10.97%	4.61%	31.30%	54.77%	148.33%	298.16%	-	-	-	-	-	-100.00%
Net Income Growth (1Y)	-84.01%	-84.76%	-5.53%	-14.57%	-22.27%	-34.38%	-43.84%	-43.96%	-42.27%	-34.23%	-44.51%	-35.72%
EPS Growth (1Y)	-92.90%	-91.84%	-52.70%	-37.04%	-43.22%	-49.98%	-61.27%	-56.75%	-55.24%	-42.03%	-48.86%	-40.60%
Valuation Metrics
P/E TTM	-73.47	-62.28	-8.43	-3.56	-1.80	-2.36	-2.36	-1.70	-1.42	-0.74	-0.64	-0.74
P/B TTM	2.36	1.84	1.78	7.66	2.64	2.84	3.70	2.23	2.24	1.10	1.12	1.09
P/S TTM	16.38	12.78	8.73	4.17	2.23	3.32	3.39	3.60	5.63	6.29	-	-
Market Cap	468.98M	381.28M	324.76M	138.72M	71.76M	94.75M	96.16M	77.42M	72.93M	45.04M	46.78M	60.10M
Enterprise Value	437.86M	322.83M	302.23M	114.72M	48.35M	56.41M	67.71M	58.21M	54.18M	25.20M	20.13M	38.48M
Calculated Values
Free Cash Flow TTM	-39.84M	-41.16M	-55.79M	-55.86M	-56.22M	-51.15M	22.80M	24.06M	27.50M	22.39M	-70.39M	-76.33M
Net Debt	-31.12M	-58.45M	-22.53M	-24.01M	-23.41M	-38.34M	-28.45M	-19.21M	-18.75M	-19.84M	-26.66M	-21.62M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-17Sale

Owner: Bjorkquist, Jeanette M

Title: PFO and PAO

Shares: 29

Price/Share: $23.25

Value: $674.25

Shares Owned: 14,560

Relationship: Officer

Ownership: Direct

2026-03-30Sale

Owner: White, Nicole S

Title: Chief Manufacturing Officer

Shares: 197

Price/Share: $27.07

Value: $5,332.79

Shares Owned: 37,477

Relationship: Officer

Ownership: Direct

2026-03-30Sale

Owner: Bjorkquist, Jeanette M

Title: PFO and PAO

Shares: 328

Price/Share: $27.07

Value: $8,878.96

Shares Owned: 11,089

Relationship: Officer

Ownership: Direct

2025-08-08Purchase

Owner: Gilead, Sciences, Inc.

Title: -

Shares: 2,295,920

Price/Share: -

Value: -

Shares Owned: 4,505,391

Relationship: TenPercentOwner

Ownership: Direct

2025-03-31Sale

Owner: White, Nicole S

Title: Chief Manufacturing Officer

Shares: 197

Price/Share: $9.85

Value: $1,940.45

Shares Owned: 11,674

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-17	Bjorkquist, Jeanette M	Officer	PFO and PAO	Direct	Sale	29	23.25	$674.25	14,560	4
2026-03-30	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	197	27.07	$5,332.79	37,477	4
2026-03-30	Bjorkquist, Jeanette M	Officer	PFO and PAO	Direct	Sale	328	27.07	$8,878.96	11,089	4
2025-08-08	Gilead, Sciences, Inc.	TenPercentOwner	-	Direct	Purchase	2,295,920	-	-	4,505,391	4
2025-03-31	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	197	9.85	$1,940.45	11,674	4
2025-03-31	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	355	9.85	$3,496.75	14,757	4
2025-03-31	Bjorkquist, Jeanette M	Officer	Principal Accounting Officer	Direct	Sale	180	9.85	$1,773.00	4,617	4
2025-03-31	Mchutchison, John G	Director	-	Direct	Sale	757	9.85	$7,456.45	18,347	4
2024-12-30	Houghton, Michael	Director	-	Indirect	Purchase	3,202	15.61	$49,983.22	3,202	4
2024-12-19	Gilead, Sciences, Inc.	TenPercentOwner	-	Direct	Purchase	940,499	21.37	$20,098,463.63	2,209,471	4
2024-11-25	Schornstein, Alexander	TenPercentOwner	-	Direct	Purchase	7,976	14.92	$119,001.92	728,113	4
2024-11-18	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	40	16.29	$651.60	11,871	4
2024-10-08	Schornstein, Alexander	TenPercentOwner	-	Direct	Purchase	10,000	14.58	$145,800.00	703,113	4
2024-10-03	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	197	14.81	$2,917.57	14,904	4
2024-10-03	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	157	14.81	$2,325.17	11,911	4
2024-08-02	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	981	14.23	$13,959.63	15,101	4
2024-08-02	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	785	14.23	$11,170.55	12,068	4
2024-07-05	Schornstein, Alexander	TenPercentOwner	-	Direct	Purchase	4,438	12.52	$55,563.76	693,113	4
2024-06-17	Gilead, Sciences, Inc.	TenPercentOwner	-	Direct	Purchase	179,500	-	-	1,268,972	4
2024-05-23	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	172	14.93	$2,567.96	12,853	4
2024-05-23	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	549	14.93	$8,196.57	16,082	4
2024-05-23	Mchutchison, John G	Director	-	Direct	Sale	2,117	14.93	$31,606.81	19,104	4
2024-05-23	Bjorkquist, Jeanette M	Officer	Principal Accounting Officer	Direct	Sale	24	14.93	$358.32	3,142	4
2024-04-30	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	1,255	12.71	$15,951.05	13,025	4
2024-04-30	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	1,569	12.71	$19,941.99	16,423	4
2024-04-01	Mchutchison, John G	Director	-	Direct	Sale	1,206	13.07	$15,762.42	21,221	4
2024-04-01	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	354	13.07	$4,626.78	13,826	4
2024-04-01	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	197	13.07	$2,574.79	10,947	4
2024-04-01	Bjorkquist, Jeanette M	Officer	Principal Accounting Officer	Direct	Sale	114	13.07	$1,489.98	3,166	4
2024-03-27	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	392	12.87	$5,045.04	14,180	4
2024-01-18	Schornstein, Alexander	TenPercentOwner	-	Direct	Purchase	345,086	0.80	$276,068.80	8,209,372	4
2023-11-21	Schornstein, Alexander	TenPercentOwner	-	Direct	Purchase	100,000	0.67	$67,000.00	7,564,292	4
2023-11-17	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	477	0.69	$329.13	93,774	4
2023-10-03	White, Nicole S	Officer	Chief Manufacturing Officer	Direct	Sale	1,891	0.80	$1,512.80	94,251	4
2023-10-03	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	2,363	0.80	$1,890.40	174,923	4
2023-10-03	Delaney, William E Iv	Officer	Chief Scientific Officer	Direct	Sale	1,891	0.80	$1,512.80	150,853	4
2023-08-02	Okazaki, Jason A	Director,Officer	CEO and President	Direct	Sale	11,827	1.09	$12,891.43	164,786	4
2023-08-02	Delaney, William E Iv	Officer	Chief Scientific Officer	Direct	Sale	9,461	1.09	$10,312.49	142,744	4
2023-07-24	Bjorkquist, Jeanette M	Officer	Principal Accounting Officer	Direct	Sale	844	1.07	$903.08	26,688	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

79.70%

Inst. Shares: 13,469,640

Shares Outstanding: 16,900,232

2025-12-31

121.62%

Inst. Shares: 13,634,444

Shares Outstanding: 11,210,934

2025-09-30

96.24%

Inst. Shares: 12,208,764

Shares Outstanding: 12,686,122

2025-06-30

162.52%

Inst. Shares: 12,442,656

Shares Outstanding: 7,655,854

2025-03-31

167.82%

Inst. Shares: 12,596,828

Shares Outstanding: 7,506,321

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	13,469,640	16,900,232	79.70%
2025-12-31	13,634,444	11,210,934	121.62%
2025-09-30	12,208,764	12,686,122	96.24%
2025-06-30	12,442,656	7,655,854	162.52%
2025-03-31	12,596,828	7,506,321	167.82%
2024-12-31	12,666,328	6,004,560	210.95%
2024-09-30	12,124,068	6,351,431	190.89%
2024-06-30	13,904,640	5,642,752	246.42%
2024-03-31	7,187,448	5,483,313	131.08%
2023-12-31	8,058,903	4,577,371	176.06%
2023-09-30	8,908,091	4,380,444	203.36%
2023-06-30	9,599,997	4,355,007	220.44%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ASSEMBLY BIOSCIENCES, INC. (ASMB) — SEC Financial Statements & Analysis

ASSEMBLY BIOSCIENCES, INC. (ASMB) is a pharmaceutical preparations company, incorporated in DE. ASSEMBLY BIOSCIENCES, INC. trades on Nasdaq as: ASMB. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ASSEMBLY BIOSCIENCES, INC. reported a -10.97% year-over-year revenue growth, a Debt-to-Equity ratio of 0.19x, a Price-to-Sales (P/S) ratio of 16.38x (TTM), a Price-to-Book (P/B) ratio of 2.36 (TTM), at a market cap of $468.98M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -10.97%
Debt To Equity: 0.19x
P/S TTM: 16.38x
P/B TTM: 2.36
Market Cap: $468.98M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ASSEMBLY BIOSCIENCES, INC. in?

ASSEMBLY BIOSCIENCES, INC. (ASMB) operates in the Pharmaceutical Preparations industry.

What is ASMB's market cap?

ASSEMBLY BIOSCIENCES, INC. (ASMB) has a market capitalization of $468.98M as of 2026-03-31.

What exchange does ASMB trade on?

ASSEMBLY BIOSCIENCES, INC. (ASMB) trades on the Nasdaq.

Where is ASSEMBLY BIOSCIENCES, INC. incorporated?

ASSEMBLY BIOSCIENCES, INC. is incorporated in DE.

ASSEMBLY BIOSCIENCES, INC. (ASMB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.